DEA supports psychedelic medicine?

DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicines

The Drug Enforcement Administration (DEA) is working to accelerate the development of federally-approved psychedelic medicines!

The agency proposed a huge increase in the production of psilocybin, psilocin, and marijuana with the goal of advancing research and drug development.

The proposed production quotas have increased to 1,500 g for psilocybin and 1,000 g for psilocin – up 2,900% and 1,900% respectively from the initial 50 g quota.